18 March 2021
Top global hires for large-cap, mid-cap and public companies
Search Highlights
Recent top global hires for large-cap, mid-cap, and public companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.
CEO/ C-suite/ Board
| Function | Focus area | Location |
|---|---|---|
| CEO | Biopharma (publicly listed) | Europe, US |
| CEO | Drug delivery systems (publicly listed) | Europe |
| Chief Operating Officer | Pharma (family owned mid-cap) | Europe |
| Chief Scientific Officer | Biopharma (mid-cap) | Europe |
| Chief Development Officer | Biopharma (clinical-stage) | US |
| Chief Medical Officer | Biotech (publicly listed) | Europe |
| Chief Financial Officer | Regenerative medicine therapies (publicly listed) | Europe |
R&D/Medical/Technical
| Function | Focus area | Location |
|---|---|---|
| Global Medical Director | Specialty pharma (mid-cap) | Europe |
| Head of Quality Assurance | Biopharma (publicly listed) | US |
| VP Manufacturing and Development | Biotech (publicly listed) | US |
| VP Clinical Sciences | Gene therapeutics technology | US |
| VP Regulatory Affairs | Global gene therapy leader | US, Europe |
| VP Medical Affairs Europe/International | Biopharma (mid-cap) | Europe |
| Executive Director, Clinical Biomarkers & Diagnostics | Biotech (top 10) | US |
| Global Head Clinical Development Biologics | Specialty pharma (mid-cap) | Europe |
| Executive Director, CMC Regulatory Affairs | Vaccines biotech (publicly listed) | US |
| Executive Director, Research Animal Health (US) | Pharma (top 10 global) | Europe |
| Director of Epidemiology & RWE | Specialty pharma (mid-cap) | Japan |
| Senior Director (US), Global Program Management | Vaccines biotech (publicly listed) | Europe |
Commercial/Functional/Strategic Leadership
| Function | Focus area | Location |
|---|---|---|
| SVP Interventional Systems EMEA | Medtech (large-cap) | Asia |
| Business Unit Director France | Animal health pharma (top 5) | US |
| Country Director Germany | Medical devices (publicly listed) | Europe |
| Business Unit Head | Health ingredients (publicly listed) | Europe |
| Head of Legal International | Biopharma (mid-cap) | Europe |
| Head of Business Intelligence | Biotech engineering services | Europe |
| Investment Director | Specialty pharma (mid-cap) | Europe |
| Director Human Resources | Biotech (publicly listed) | Europe |
| Head of Business Excellence Belgium | Pharma (top 10 global) | Europe |
Related
-
Events
AESC Global Summit on Leadership
17 November 2025 – 18 November 2025
-
Company News
LSX World Congress conference with Justine McIlroy, Client Partner
12 May 2023
-
Thought Leadership
Five Shifts to Digital Personalized Healthcare
10 May 2023
-
Company News
Digital Health UK CEO and Commercial Leaders Breakfast
28 March 2023
